Quadracel® is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis and poliomyelitis
For intramuscular use only
Each 0.5 mL dose is formulated to contain 15 Lf diphtheria toxoid, 5 Lf tetanus toxoid, acellular pertussis antigens [20 mcg detoxified pertussis toxin (PT), 20 mcg filamentous hemagglutinin (FHA), 3 mcg pertactin (PRN), 5 mcg fimbriae types 2 and 3 (FIM)], and inactivated polioviruses [29 D-antigen units (DU) Type 1 (Mahoney), 7 DU Type 2 (MEF-1), 26 DU Type 3 (Saukett)]
Manufacturer # 49281056415
Brand Quadracel®
Manufacturer Sanofi Pasteur
Country of Origin Canada
Application DTaP and Polio Vaccine
Container Type Prefilled Syringe
Dosage Form Injection
Generic Drug Code 51904
Generic Drug Name Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
Is_Active_Vendor Y
Is_DSCSA Y
Is_Discontinued N
Is_Medical_Device Y
Lot_Tracking_Flag Y
NDC Number 49281056415
On_Allocation N
Product Dating McKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements Requires Refrigeration
Strength 15 Lf - 5 Lf - 20 mcg - 62 DU / 0.5 mL
Supplier_ID 488026
Type Intramuscular
UNSPSC Code 51201631
User Indicated for People 4 Through 6 Years of Age
Volume 0.5 mL
